（原标题：融捷健康(300247.SZ)：在部分远红外桑拿房产品上运用了AI语音识别智能控制系统） 格隆汇12月9日丨融捷健康(300247.SZ)在投资者互动平台表示，，公司在部分远红外桑拿房产品上运用 了AI语音识别智能控制系统，这只是产品功能的更新，对公司营收不产生重大影响。 ...

格隆汇12月9日丨融捷健康(300247.SZ)在投资者互动平台表示，，公司在部分远红外桑拿房产品上运用 了AI语音识别智能控制系统，这只是产品功能的更新，对公司营收不产生重大影响。 ...

（记者 王晓波） 融捷健康（300247.SZ）12月9日在投资者互动平台表示，公司在部分远红外桑拿房产品上运用了AI语音 识别智能控制系统，这只是产品功能的更新，对公司营收不产生重大影响。 每经AI快讯，有投资者在投资者互动平台提问：请问公司有没有把AI技术应用在公司产品中？主要是 哪些？ ...

Group 1 - The core viewpoint of the news is that Rongjie Health has seen a stock price increase of 6.13%, reaching 5.02 CNY per share, with a total market capitalization of 4.036 billion CNY [1] - Rongjie Health, established on April 21, 1995, and listed on July 29, 2011, is primarily engaged in the production and sales of health products, including far-infrared sauna rooms, air purifiers, fitness equipment, and massage chairs [1] - The main revenue composition of Rongjie Health includes 77.30% from far-infrared therapy sauna rooms, 13.66% from other products, 4.91% from portable sauna products, and 4.13% from air purifiers [1] Group 2 - Among the top ten circulating shareholders of Rongjie Health, a fund under Dacheng Fund has entered the list, holding 3.6493 million shares, which accounts for 0.45% of the circulating shares [2] - The Dacheng Zhongzheng 360 Internet + Index A fund has achieved a year-to-date return of 39.52% and a one-year return of 40.8% [2] - The fund manager, Xia Gao, has a tenure of nearly 11 years, with the fund's best return during this period being 223.87% [3]

Group 1 - The core viewpoint of the news is that Rongjie Health's stock has experienced a significant decline, with a 5.06% drop on November 21, leading to a cumulative decline of 11.31% over three consecutive days [1] - As of the report, Rongjie Health's stock price is at 4.69 yuan per share, with a trading volume of 1.05 billion yuan and a turnover rate of 2.72%, resulting in a total market capitalization of 37.71 billion yuan [1] - The company, established in 1995 and listed in 2011, primarily focuses on health product sales, with its main revenue sources being far-infrared therapy sauna rooms (77.30%), other products (13.66%), portable sauna products (4.91%), and air purifiers (4.13%) [1] Group 2 - From the perspective of major circulating shareholders, Dazhong Fund's Dazhong Zhongzheng 360 Internet + Index A (002236) has entered the top ten circulating shareholders, holding 3.6493 million shares, which is 0.45% of the circulating shares [2] - The fund has incurred a floating loss of approximately 912,300 yuan today, with a total floating loss of 2.2991 million yuan during the three-day decline [2] - The Dazhong Zhongzheng 360 Internet + Index A fund, established in February 2016, has a current scale of 788 million yuan and has achieved a year-to-date return of 38.22%, ranking 871 out of 4208 in its category [2]

Group 1 - The core point of the news is that Rongjie Health's stock price dropped by 5.04% to 5.09 CNY per share, with a trading volume of 232 million CNY and a turnover rate of 5.59%, resulting in a total market capitalization of 4.093 billion CNY [1] - Rongjie Health Technology Co., Ltd. is based in Hefei, Anhui Province, established on April 21, 1995, and listed on July 29, 2011. The company primarily engages in the production and sales of health products, including far-infrared sauna rooms, air purifiers, fitness equipment, massage chairs, and various health-related small products [1] - The revenue composition of Rongjie Health's main business includes 77.30% from far-infrared therapy sauna rooms, 13.66% from other products, 4.91% from portable sauna products, and 4.13% from air purifiers [1] Group 2 - Among the top ten circulating shareholders of Rongjie Health, a fund under Dacheng Fund ranks first. The Dacheng CSI 360 Internet + Index A (002236) entered the top ten circulating shareholders in the third quarter, holding 3.6493 million shares, accounting for 0.45% of the circulating shares [2] - The Dacheng CSI 360 Internet + Index A (002236) was established on February 3, 2016, with a latest scale of 788 million CNY. Year-to-date, it has achieved a return of 41.54%, ranking 792 out of 4208 in its category; over the past year, it has returned 50.04%, ranking 442 out of 3956; and since inception, it has returned 233.83% [2]

Group 1 - The core viewpoint of the news is that Rongjie Health has seen a stock price increase of 5.07%, reaching 4.77 CNY per share, with a trading volume of 1.52 billion CNY and a turnover rate of 4.11%, resulting in a total market capitalization of 38.35 billion CNY [1] - Rongjie Health Technology Co., Ltd. is based in Hefei, Anhui Province, established on April 21, 1995, and listed on July 29, 2011. The company primarily focuses on the production and sales of health products, including far-infrared sauna rooms, air purifiers, fitness equipment, massage chairs, and various health-related small products [1] - The main revenue composition of Rongjie Health includes 77.30% from far-infrared therapy sauna rooms, 13.66% from other products, 4.91% from portable sauna products, and 4.13% from air purifiers [1] Group 2 - Among the top ten circulating shareholders of Rongjie Health, a fund under Dacheng Fund ranks first. The Dacheng CSI 360 Internet + Index A (002236) entered the top ten circulating shareholders in the third quarter, holding 3.6493 million shares, which accounts for 0.45% of the circulating shares [2] - The Dacheng CSI 360 Internet + Index A (002236) was established on February 3, 2016, with a latest scale of 788 million CNY. Year-to-date returns are 39.53%, ranking 1082 out of 4216 in its category; the one-year return is 35.95%, ranking 596 out of 3937; and since inception, the return is 229.09% [2]

Core Viewpoint - Rongjie Health, established in 1995 and listed in 2011, focuses on health products, particularly far-infrared sauna rooms, and has diversified product offerings [1] Group 1: Business Performance - In Q3 2025, Rongjie Health reported revenue of 652 million yuan, ranking third in the industry, with the leader, Aojiahua, at 3.724 billion yuan [2] - The main product, far-infrared therapeutic sauna rooms, generated 309 million yuan, accounting for 77.3% of total revenue [2] - The net profit for the same period was 91.49 million yuan, ranking second in the industry, with the leader, Rongtai Health, at 111 million yuan [2] Group 2: Financial Ratios - As of Q3 2025, Rongjie Health's debt-to-asset ratio was 17.13%, lower than the industry average of 25.55% [3] - The gross profit margin for Q3 2025 was 36.76%, higher than the industry average of 34.44% [3] Group 3: Executive Compensation - The chairman, Xing Fenling, received a salary of 278,600 yuan in 2024, a decrease of 171,900 yuan from 2023 [4] - The general manager, Qian Xiaodong, had a salary of 699,300 yuan in 2024, down by 89,200 yuan from the previous year [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 1.04% to 29,300 [5] - The average number of circulating A-shares held per shareholder increased by 1.05% to 27,400 [5]

Core Viewpoint - Rongjie Health's main supply chain for its U.S. subsidiary is sourced from China, and the company is currently evaluating measures to potentially shift its supply chain [1] Summary by Relevant Sections - **Sales to the U.S.**: In 2024, the company's sales to the U.S. are projected to be $61.985 million, with $5.3234 million coming from domestic factory exports and $56.6615 million from sales made by the U.S. subsidiary [1] - **Product Classification**: The far-infrared sauna rooms sold to the U.S. are classified as wood products and do not qualify for the "reciprocal tariff" exemption [1] - **Supply Chain Assessment**: The company is assessing measures related to the potential transfer of its supply chain [1]